Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 2001

View Archived Issues

Abgenix discusses first-quarter highlights

Taiwan researchers study plant-derived sesquiterpene as potential antihypertensive agent

Electrophysiological profile of amiodarone homologues examined in guinea pig hearts

Gilead submits MAA for tenofovir DF in Europe

ICN considers licensing levovirin

Pharmacyclics reacquires worldwide rights to Lutrin

Sheffield initiates development of inhaled interferon gamma for respiratory diseases

Phase II trial of irofulven for treatment of glioma commences

Preclinical antiproliferative activity of A-105972 characterized

Antithrombotic activity of agkistin related to platelet gpIb antagonism

Cell Pathways and BMS to initiate drug combination study for first-line NSCLC

Atrix's periodontal disease treatment approved in several European countries

Cathepsin S inhibitor collaboration extended by Medivir, Genzyme; licensing partner sought

Novel approach to therapeutic HBV vaccine taken by StressGen

Sustained benefits seen for Visudyne therapy over three years of follow-up

First quarter at GenVec marked by progress in TNFerade and PEDF programs

Potential new hypnotic Ro-41-3696 tested in multiple-dose clinical study in elderly volunteers

Neurocrine Biosciences reports clinical development progress

Preclinical profile of Bay-59-8862, a new taxane, reviewed in Drugs of the Future

MAbs prepared at Genentech act as HGF receptor antagonists

French lab patents new nicotinic acetylcholine receptor subunit and uses thereof

Novel P2T receptor antagonists identified at AstraZeneca as potential antithrombotics

Theratechnologies and Alza to develop ThGRF in a Macroflux system

Inhibitors of factor Xa under development at Cor Therapeutics

Bayer describes dicarboxylic acid derivatives useful for cardiovascular disorders

Dermatological stilbene compounds in the Galderma pipeline

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...